News about names
Professor of Translational Pharmacology at University of Southern Denmark
Tore B. Stage assumes the position of Professor of Pharmacology at the Department of Clinical Pharmacology, Pharmacy, and Environmental Medicine at the Institute of Health Services Research at University of Southern Denmark (SDU), where he also serves as a research leader.
Tore B. Stage conducts research on drugs and why they have different effects in individuals. His research area is characterized by combining laboratory research with patient data, which allows for the explanation of observations from patients through complex cellular mechanisms of action. The concept of "translational pharmacology" precisely refers to this close collaboration between the laboratory and treatment.
A particular area of interest is painful skin side effects of chemotherapy. These painful skin side effects significantly reduce the quality of life for many cancer patients during and after chemotherapy. His research group investigates the underlying mechanism of peripheral neuropathy by examining pain-sensing cells in the laboratory and combining it with clinical data from patients. Tore B. Stage holds a patent for a new drug that aims to prevent this side effect. The drug was recently tested in animals, and it is expected to be tested on humans within the next year.
Tore B. Stage is 35 years old and graduated as a pharmacist from SDU in 2012. After completing his master's degree in pharmacy, he defended his Ph.D. at SDU under the supervision of Professor Kim Brøsen. During his Ph.D., Tore Stage had a research stay at Uppsala in Sweden. He then continued his career, which eventually took him to the University of California, San Francisco when he received an individual postdoctoral grant from the Danish Independent Research Council in 2015.
After his stay in San Francisco, he returned to SDU, where he was employed as an assistant professor from 2017 to 2019, followed by an associate professorship from 2019 to 2023, and now as a professor. Tore B. Stage has thus been affiliated with the same department he is now becoming a professor at since he wrote his thesis more than 10 years ago.
A particular area of interest is painful skin side effects of chemotherapy. These painful skin side effects significantly reduce the quality of life for many cancer patients during and after chemotherapy. His research group investigates the underlying mechanism of peripheral neuropathy by examining pain-sensing cells in the laboratory and combining it with clinical data from patients. Tore B. Stage holds a patent for a new drug that aims to prevent this side effect. The drug was recently tested in animals, and it is expected to be tested on humans within the next year.
Tore B. Stage is 35 years old and graduated as a pharmacist from SDU in 2012. After completing his master's degree in pharmacy, he defended his Ph.D. at SDU under the supervision of Professor Kim Brøsen. During his Ph.D., Tore Stage had a research stay at Uppsala in Sweden. He then continued his career, which eventually took him to the University of California, San Francisco when he received an individual postdoctoral grant from the Danish Independent Research Council in 2015.
After his stay in San Francisco, he returned to SDU, where he was employed as an assistant professor from 2017 to 2019, followed by an associate professorship from 2019 to 2023, and now as a professor. Tore B. Stage has thus been affiliated with the same department he is now becoming a professor at since he wrote his thesis more than 10 years ago.
Meet the professor
Tore B. Stage is research leader and professor of Pharmacology at the Department of Clinical Pharmacology, Pharmacy, and Environmental Medicine at the Institute of Health Services Research at SDU.